GUBRA (GUBRA) News
Track canonical SquawkNews coverage tagged to GUBRA, GUBRA. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Gubra partner Hemab Therapeutics doses first volunteer in HMB-003 Phase 1
Gubra said Hemab Therapeutics dosed the first healthy volunteer in a randomized, placebo-controlled Phase 1 trial of HMB-003, a peptide-based plasmin inhibitor for heavy menstrual bleeding.
EQUITY | Sep 17, 2026, 12:45 PM UTC
L
Gubra to participate in Morgan Stanley Global Healthcare Conference
Gubra will take part in the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September 14-16. CEO Markus Rohrwild joins a fireside chat on September 16 at 1:50 p.m. EDT.
EQUITY | Sep 09, 2026, 01:00 PM UTC